Organization
Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain
4 abstracts
Abstract
ANTI-HMGCR AUTOANTIBODY LEVELS IN THE FOLLOW-UP OF STATIN-INDUCED IMMUNE-MEDIATED NECROTIZING MYOPATHY. MULTICENTRIC STUDY OF 24 PATIENTSOrg: Hospital de Sierrallana, Rheumatology, Torrelavega, Spain, Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain, National Institute of Geriatrics, Rheumatology and Rehabilitation, Rheumatology, Warsaw, Poland, Medical University of Warsaw, Neurology, Warsaw, Poland, Department of Medicine, Karolinska Institute, Rheumatology, Stockholm, Sweden,
Abstract
BIOLOGICAL THERAPY IN REFRACTORY NEUROBEHÇET’S DISEASE. MULTICENTER STUDY OF 42 PATIENTSOrg: Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain, Hospital de Sierrallana, Rheumatology, Torrelavega, Spain, Hospital Universitario La Princesa, Rheumatology, Madrid, Spain, Hospital Universitario de Donostia, Rheumatology and Ophtalmology, San Sebastián, Spain, Hospital 12 de Octubre, Rheumatology, Madrid, Spain,
Abstract
BIOLOGICAL THERAPY IN UVEITIS ASOCIATED TO AXIAL SPONDYLOARTHRITIS. SINGLE CENTER UNIVERSITY STUDYOrg: Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain,
Abstract
ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS. SPANISH NATIONAL REGISTRY IN A REAL-WORLD SETTINGOrg: Hospital Universitario Marqués de Valdecilla, Rheumatology, Santander, Spain, IDIVAL, Immunopathology Group, Santander, Spain, Hospital Universitario de León, Rheumatology, León, Spain, Hospital Universitari Germans Trias i Pujol, Rheumatology, Badalona, Barcelona, Spain, Hospital Universitario Doctor Peset, Rheumatology, Valencia, Spain,